Medpace Holdings, Inc. Files 8-K with Financial Updates
Ticker: MEDP · Form: 8-K · Filed: Apr 22, 2024 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | 8-K |
| Filed Date | Apr 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: MEDP
TL;DR
MEDPACE FILED AN 8-K ON 4/22 WITH FINANCIALS - CHECK IT OUT
AI Summary
On April 22, 2024, Medpace Holdings, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits related to the company's performance. Medpace Holdings, Inc. is incorporated in Delaware and is headquartered in Cincinnati, Ohio.
Why It Matters
This 8-K filing provides investors with crucial updates on Medpace Holdings, Inc.'s financial condition and operational results, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report of financial information and does not indicate any unusual risks.
Key Players & Entities
- Medpace Holdings, Inc. (company) — Registrant
- April 22, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Cincinnati, Ohio (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Medpace Holdings, Inc.?
The primary purpose of this 8-K filing is to report on Medpace Holdings, Inc.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
When was this 8-K report filed by Medpace Holdings, Inc.?
This 8-K report was filed on April 22, 2024.
In which state is Medpace Holdings, Inc. incorporated?
Medpace Holdings, Inc. is incorporated in Delaware.
What is the principal executive office address for Medpace Holdings, Inc.?
The principal executive office address for Medpace Holdings, Inc. is 5375 Medpace Way, Cincinnati, Ohio 45227.
What is the IRS Employer Identification Number for Medpace Holdings, Inc.?
The IRS Employer Identification Number for Medpace Holdings, Inc. is 32-0434904.
Filing Stats: 552 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-04-22 16:15:30
Key Financial Figures
- $0.01 — hange on which registered Common Stock $0.01 par value MEDP NASDAQ Global Select Mar
Filing Documents
- medp-20240422.htm (8-K) — 26KB
- medp-20240422exx991.htm (EX-99.1) — 143KB
- medpace-logoxonxwhite.jpg (GRAPHIC) — 10KB
- 0001668397-24-000089.txt ( ) — 319KB
- medp-20240422.xsd (EX-101.SCH) — 2KB
- medp-20240422_lab.xml (EX-101.LAB) — 21KB
- medp-20240422_pre.xml (EX-101.PRE) — 12KB
- medp-20240422_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On April 22, 2024, Medpace Holdings, Inc. (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2024. The full text of the press release was posted on the Company's internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated April 2 2 , 20 2 4 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MEDPACE HOLDINGS, INC. Date: April 22, 2024 By: /s/ Kevin M. Brady Kevin M. Brady, Chief Financial Officer